SP7 and ocular melanoma: Osx promoter activities were significantly decreased by recombinant Sostdc1 (Fig. 5b) and Dkk1 (Supplementary Fig. S5) treatment in a concentration-dependent manner, while they significantly increased by OM treatment for differentiation compared to the undifferentiated control (UD).